U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,639 records

Showing results for "last months".

  1. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/G9P7o8jDh4J3NnAk6y-SYL
    December 01, 2011 - Preventive Services Task Force (USPSTF) last reviewed the evidence on prostate cancer screening (4) and … Benefits and harms of treatments for prostate cancer were last reviewed by the USPSTF in 2002 (8). … studies that evaluated bowel function serially, effects seemed to be most pronounced in the first few months

  2. ACKNOWLEDGEMENTS (pdf file)

    hcup-us.ahrq.gov/reports/race/NASHPDisparitiesReport.pdf
    January 01, 2020 - Last modified February 17, 2010. 12 Public Law 111–148 http://docs.house.gov/energycommerce/ACAcon.pdf … Last year, the event included discussion of how DHSS can more fully integrate work to address disparities

  3. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
    February 01, 2012 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … We have split the last sentence to state 1) the review will be out of date in the next 1-2 years, 2

  4. Ced-Topic-Refinement (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
    November 01, 2022 - 7 Century Cures Act34 and the transcript of the MEDCAC meeting in 2012 when the CED process was last … The results must be made public within 12 months of the study’s primary completion date, which is the

  5. Analysis of Requirements for Coverage With Evidence Development (CED) - Topic Refinement (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/ced-topic-refinement.pdf
    November 01, 2022 - Century Cures Act34 and the transcript of the MEDCAC meeting in 2012 when the CED process was last … The results must be made public within 12 months of the study’s primary completion date, which is

  6. VU EPC DBD Protocol_AHRQ comments_revised_clean (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
    January 30, 2014 - reviews and guidelines We identified a number of systematic reviews and meta-analyses published in the last … review comments are documented and will be published three months

  7. Preeclampsia Screening Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgA7neX9UurPQRh3pJaYXY
    April 25, 2017 - The last surveillance was con- ducted on October 5, 2016, and identified no relevant new studies. … randomised trial comparing magnesium sulphate with placebo for pre-eclampsia: outcome for children at 18 months

  8. Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R33bUm6oyjhWnbw96pJHwE
    April 01, 2009 - self-reported depression symptoms), and analyzed intention-to-treat populations, most often by using LOCF (last-observation-carried-forward … assessed criterion standard for MDD or depression not APPENDIX 2 Continued otherwise specified within 2 months

  9. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - group, suggesting a possible rebound effect. 18 Another small RCT 45 of fair quality found that 4 months

  10. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
    March 01, 2007 - Another small RCT (45) of fair quality found that 4 months of sulindac, 30 mg/d (non-ASA NSAID), did

  11. AHRQ_DHR_2022_Annual_Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/page/ahrq-dhr-2022-year-in-review.pdf
    January 01, 2022 - In the last year of the study, the team will develop a toolkit to support widespread dissemination

  12. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - , Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months … No Israel Hemodialysis patients with chronic pain NR Study required cannabis abstention at least 3 months … Europe NPP Multiple sclerosis Excluded patients who used dronabinol within 1 year or marijuana within last

  13. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - , Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months … No Israel Hemodialysis patients with chronic pain NR Study required cannabis abstention at least 3 months … Europe NPP Multiple sclerosis Excluded patients who used dronabinol within 1 year or marijuana within last

  14. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - , Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months … No Israel Hemodialysis patients with chronic pain NR Study required cannabis abstention at least 3 months … Europe NPP Multiple sclerosis Excluded patients who used dronabinol within 1 year or marijuana within last

  15. DRN: Report 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
    July 01, 2009 - identifying initial treatment for a condition (e.g., first anti- hypertensive drug dispensing within six months … criteria, e.g, incident users of a new drug without any history of CVD or use of statins within prior 9 months

  16. Disposition of Comments for CER 163 Appropriate Antibiotics (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
    January 27, 2016 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … the bullet: "Measure resistance as an outcome" should take into account that resistance may take months

  17. Prostate-Specific Antigen–Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the USPSTF (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/b-rsH7WPpNC3uL9NeoXBfF
    May 08, 2018 - The last surveillance search was con- ducted in February 2018; during ongoing surveillance, we identi

  18. Disposition of Comments for CER 157 Appendicitis (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_disposition-comments.pdf
    December 14, 2015 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months

  19. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/h8qcZeQ68AQPS9DemArgXX
    July 13, 2021 - The last surveil- lance was conducted on May 21, 2021. … modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months

  20. Final-Hit-Enabled-Quality-Measurement-Snapshot (pdf file)

    digital.ahrq.gov/sites/default/files/docs/publication/final-hit-enabled-quality-measurement-snapshot.pdf
    July 01, 2012 - Foreword Health information technology (health IT) has seen a tremendous increase in adoption over the last … His statement is supported by multiple reports that show a dramatic increase in adoption over the last
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (1564)

effectivehealthcare.ahrq.gov (859)

digital.ahrq.gov (591)

psnet.ahrq.gov (580)

www.uspreventiveservicestaskforce.org (434)

hcup-us.ahrq.gov (387)

meps.ahrq.gov (102)

integrationacademy.ahrq.gov (43)

cdsic.ahrq.gov (36)

cds.ahrq.gov (25)

pso.ahrq.gov (10)

datatools.ahrq.gov (4)

cahpsdatabase.ahrq.gov (3)

qualityindicators.ahrq.gov (1)